WallStreetZenWallStreetZen

NASDAQ: LBPH
Longboard Pharmaceuticals Inc Stock Ownership - Who owns Longboard Pharmaceuticals?

Insider buying vs selling

Have Longboard Pharmaceuticals Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Arena Pharmaceuticals IncInsider2024-01-253,978,540$24.25
$96.48MSell

1 of 1

LBPH insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when LBPH insiders and whales buy or sell their stock.

LBPH Shareholders

What type of owners hold Longboard Pharmaceuticals Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Cormorant Asset Management LP6.53%2,353,141$46.47MInstitution
Fmr LLC4.58%1,649,503$32.58MInstitution
Price T Rowe Associates Inc4.52%1,626,982$32.13MInstitution
Farallon Capital Management LLC4.33%1,560,500$30.82MInstitution
Polar Capital Holdings PLC2.78%1,000,000$19.75MInstitution
Ikarian Capital LLC2.72%979,462$19.34MInstitution
Integral Health Asset Management LLC2.50%900,000$17.78MInstitution
Blackrock Inc2.42%869,879$17.18MInstitution
Point72 Asset Management LP2.29%825,000$16.29MInstitution
Vanguard Group Inc2.18%786,433$15.53MInstitution

1 of 3

LBPH vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
LBPH45.89%0.09%Net Selling
RGNX76.15%23.85%Net SellingNet Buying
PLRX70.74%29.26%Net Selling
ELVN46.22%53.78%Net SellingNet Selling
ARCT87.10%12.90%Net SellingNet Selling

Longboard Pharmaceuticals Stock Ownership FAQ

Who owns Longboard Pharmaceuticals?

Longboard Pharmaceuticals (NASDAQ: LBPH) is owned by 45.89% institutional shareholders, 0.09% Longboard Pharmaceuticals insiders, and 54.02% retail investors. Cormorant Asset Management LP is the largest individual Longboard Pharmaceuticals shareholder, owning 2.35M shares representing 6.53% of the company. Cormorant Asset Management LP's Longboard Pharmaceuticals shares are currently valued at $46.47M.

If you're new to stock investing, here's how to buy Longboard Pharmaceuticals stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.